- Home
- GVH vs PASG Comparison
GVH vs PASG Comparison
Compare GVH & PASG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GVH
- PASG
- Stock Information
- Founded
- GVH 2016
- PASG 2017
- Country
- GVH Australia
- PASG United States
- Employees
- GVH N/A
- PASG N/A
- Industry
- GVH
- PASG Biotechnology: Pharmaceutical Preparations
- Sector
- GVH
- PASG Health Care
- Exchange
- GVH Nasdaq
- PASG Nasdaq
- Market Cap
- GVH 21.3M
- PASG 20.3M
- IPO Year
- GVH 2023
- PASG 2020
- Fundamental
- Price
- GVH $0.04
- PASG $5.58
- Analyst Decision
- GVH Strong Buy
- PASG Strong Buy
- Analyst Count
- GVH 1
- PASG 3
- Target Price
- GVH $0.40
- PASG $153.33
- AVG Volume (30 Days)
- GVH 122.3M
- PASG 50.6K
- Earning Date
- GVH 02-12-2025
- PASG 08-07-2025
- Dividend Yield
- GVH N/A
- PASG N/A
- EPS Growth
- GVH 12.04
- PASG N/A
- EPS
- GVH 0.09
- PASG N/A
- Revenue
- GVH $16,540,178.00
- PASG N/A
- Revenue This Year
- GVH N/A
- PASG N/A
- Revenue Next Year
- GVH N/A
- PASG N/A
- P/E Ratio
- GVH $0.39
- PASG N/A
- Revenue Growth
- GVH N/A
- PASG N/A
- 52 Week Low
- GVH $0.03
- PASG $5.14
- 52 Week High
- GVH $1.82
- PASG $26.60
- Technical
- Relative Strength Index (RSI)
- GVH 21.05
- PASG 40.90
- Support Level
- GVH $0.07
- PASG $5.50
- Resistance Level
- GVH $0.09
- PASG $6.41
- Average True Range (ATR)
- GVH 0.01
- PASG 0.97
- MACD
- GVH 0.01
- PASG -0.26
- Stochastic Oscillator
- GVH 1.94
- PASG 12.96
About GVH Globavend Holdings Limited
Globavend Holdings Ltd is an e-commerce logistics provider, it provides integrated cross-border logistics services from Hong Kong to Australia and New Zealand, where it provides customers with a one-stop solution from parcel consolidation to air freight forwarding, customs clearance, on-carriage parcel transportation and delivery. It operates in logistics and freight forwarding industry, which involves the provision of services such as freight transport, freight forwarding, warehouse management, and distribution.
About PASG Passage Bio Inc.
Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease. The Company operates in a single reportable segment, developing and advancing genetic medicines designed to target critical underlying pathology of neurodegenerative diseases.